Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic effect of dalfampridine in Devic syndrome
IRCT20210917052506N1Phase 2Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of dalfampridine in Neuromyelitis Optica Spectrum Disorder (NMOSD), sponsored by Isfahan University of Medical Sciences. Started Oct 2021; status: completed.
02
Drugs
dalfampridine
03
Conditions
Neuromyelitis Optica Spectrum Disorder (NMOSD)
Beyond the preview
Go deeper on IRCT20210917052506N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210917052506N1.